insights_auto
Why is TNDM up 4.45%?
Dive Deeperchevron_right
TNDM:NASDAQ
Tandem Diabetes Care Inc
$16.42
arrow_upward
+4.45%(+0.70) 1D
$16.42
0.00% (0.00)
bedtimeAfter hours
Closed: Sep 28, 4:00:00 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for TNDM...
Open
$15.60
High
$16.54
Low
$15.52
Mkt. cap
1.14B
Avg. vol.
1.85M
Volume
2.85M
52-wk high
$29.65
52-wk low
$11.46
EPS
-$0.93
Beta
1.55
Shares outstanding
69.58M
No. of employees
2K
Open
$15.60
High
$16.54
Low
$15.52
Mkt. cap
1.14B
Avg. vol.
1.85M
Volume
2.85M
52-wk high
$29.65
52-wk low
$11.46
EPS
-$0.93
Beta
1.55
Shares outstanding
69.58M
No. of employees
2K
News stories
From web sources and news partners
Simply Wall Street
·
8 hours ago
Tandem Diabetes Care (TNDM) Could Be 46% Undervalued As Mobi Reaches 12 Markets
Stock Titan
·
16 hours ago
A diabetes pump small enough for a jeans coin pocket is now shipping abroad
Profile
Tandem Diabetes Care, Inc. is an American medical-device company that develops and markets insulin pumps, automated insulin delivery systems and diabetes-management software. Headquartered in San Diego, California, its principal pump platforms are the t:slim X2 and Tandem Mobi, both of which use the company's Control-IQ+ software with compatible continuous glucose monitors.
Tandem was founded in 2006 and introduced its first pump, the touchscreen t:slim, in 2012. The company became publicly traded on the Nasdaq in 2013. By the end of 2025 it reported an in-warranty user base of nearly 500,000 people in more than 25 countries and annual sales of $1.015 billion. Wikipedia
About Tandem Diabetes Care Inc
CEOJohn Sheridan
Employees2.5K
FoundedJan 2006
Headquarters-
SectorMedical device
Websitetandemdiabetes.com